Clarivate Plc Dossier
Qualitative Analysis
Business overview
Clarivate Plc (NYSE: CLVT) is a leading global provider of transformative intelligence solutions. The company supports the entire innovation lifecycle, from cultivating curiosity to protecting critical intellectual property (IP) assets. Clarivate operates through three primary segments: Academia & Government (A&G), Intellectual Property (IP), and Life Sciences & Healthcare (LS&H). Across these segments, it offers enriched data, insights, analytics, workflow solutions, and tech-enabled services. Key proprietary brands and platforms include Web of Science, ProQuest, Derwent, CompuMark, MarkMonitor, and Cortellis. Incorporated in Jersey, Channel Islands, Clarivate maintains its principal executive offices in London, United Kingdom.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Launched in early 2025, the VCP is built around four core pillars: business model optimization, improved sales execution, accelerated AI innovation utilizing proprietary data assets, and portfolio rationalization.
Expected impact: Aims to simplify and optimize the business model, improve commercial effectiveness, expand margins, increase free cash flow generation, and transition to a subscription-first model, increasing the organic recurring revenue mix to approximately 88%-90%.
Deployment of generative and agentic AI capabilities across flagship product portfolios, including the launch of AI-native solutions like IPOne and the Cortellis Regulatory Intelligence AI Assistant.
Expected impact: Enhances product value, improves customer retention, and drives operational efficiencies by automating internal workflows and delivering context-aware, referenced answers to users.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Recent Acquisitions
Rowan Patents is a provider of intellectual property data, software, and related support services. The acquisition aligns with Clarivate's strategy to strengthen its Intellectual Property segment by integrating advanced patent drafting and analytics software.
Financial impact: Transaction value was undisclosed; the acquisition contributes to the recurring subscription revenue base of the IP segment.
Strategic Partnerships
In March 2026, Clarivate integrated its Cortellis Regulatory Intelligence (CRI) with Anthropic's Claude AI assistant via the open Model Context Protocol (MCP). This allows biopharma and clinical research organizations to securely access authoritative regulatory data directly within their Claude AI workflows.
Terms: Financial terms were not disclosed.
Announced in June 2025, this partnership previews a deep integration roadmap for Libby, Kanopy, and Sora with Clarivate's Vega Discover platform, enhancing digital content access for public and academic libraries.
Terms: Financial terms were not disclosed.